CORCEPT THERAPEUTICS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Corcept Therapeutics Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Corcept Therapeutics Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $15.9M, a 7.47% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $15.9M +$1.11M +7.47% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $14.8M +$1.87M +14.4% Dec 31, 2022 10-K 2024-02-15
Q4 2021 $13M +$1.39M +12% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $11.6M +$171K +1.5% Dec 31, 2020 10-K 2022-02-15
Q4 2019 $11.4M +$226K +2.02% Dec 31, 2019 10-K 2021-02-23
Q4 2018 $11.2M -$1.29M -10.3% Dec 31, 2018 10-K 2020-02-24
Q4 2017 $12.5M -$117M -90.4% Dec 31, 2017 10-K 2019-02-26
Q4 2016 $129M -$4.28M -3.2% Dec 31, 2016 10-K 2018-02-28
Q4 2015 $134M -$2.42M -1.78% Dec 31, 2015 10-K 2017-03-06
Q4 2014 $136M +$15.9M +13.2% Dec 31, 2014 10-K 2016-03-10
Q4 2013 $120M +$15.9M +15.3% Dec 31, 2013 10-K 2015-03-13
Q4 2012 $104M +$14M +15.5% Dec 31, 2012 10-K 2014-03-14
Q4 2011 $90.2M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.